IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025
1. ImmunoPrecise Antibodies to host Q3 2025 results call on March 13. 2. Impactful financial results and business highlights expected to be discussed.